4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-026744
EVP, COO, Head of Commercial sold 548 shares at $21.18 ($11,607)
- EVP, COO, Head of Commercial acquired 1,567 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Teehan Brendan EVP, COO, Head of Commercial | 2023-04-29 | Option exercise | +1,567 | 10,035 | D | ||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-05-01 | Sale | −548 | $21.18 | $11,607 | 9,487 | D |
| Derivatives | |||||||
| Teehan Brendan EVP, COO, Head of Commercial | 2023-04-29 | Option exercise · Restricted Stock Units | −1,567 | 0 | D | ||
| Open-market sales · 548 sh · avg $21.18 · $11,607 | |||||||
Loading xslF345X04/doc4.xml…